Merck

Arizona couple admits in court to faking cancer-curing 'smart chip' device

At clinics in Arizona and several other states, Mary Blakley and her husband told patients that, for just $300, they could provide a full-body scan to detect a variety of potential illnesses.

 Dividing cancer cell
 BetterSeeds CEO, Ido Margalit

New Collaboration to validate CRISPR Genome-editing tools in plants

An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters on October 26, 2021.

Cheap version of Merck COVID pill to be made for poorer nations

 DR. ELIAV BARR, senior vice president and head of global medical affairs at Merck Research Laboratories in Pennsylvania.

The toxic brew of politics and COVID-19


Merck's COVID-19 pill to arrive in Israel within two weeks

Molnupiravir received Emergency Use Authorization on Thursday evening in Israel. It is used to treat mild to moderate coronavirus in adults.

An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters on October 26, 2021.

Britain approves Merck's COVID-19 pill

The green light is the first for an oral treatment for COVID-19 and the first for a COVID-19 drug that will be administered widely in the community.

 An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.

The world is fighting for COVID treatments, here’s how Israel is helping

Israel has played – and continues to play – a significant role in the fight for a cure for corona.

 An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.

Pfizer, AstraZeneca help launch 'computational science' lab in Israel

A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.

ISRAELI BIOTECH start-up Atox Bio is developing a drug that it hopes will treat those suffering from flesheating bacteria.

Merck seeks first US authorization for COVID-19 tablet

An authorization from the US Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken at home.

 The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018.

Merck says deal signed with Singapore on COVID-19 antiviral pill

Though Singapore's health ministry did not immediately confirm the deal, it would be the fourth country to enter talks of purchase with Merck.

 An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.